TILE 06 · THE QUESTION INDEX
BPC-157 TB-500 FAQ, answered from the record
Twenty-five direct answers on the Wolverine blend — definition, mechanism, dose context, safety, and the regulatory record — each cited where it makes a quantitative claim.
Definition and Purpose
These answers cover what the BPC-157 TB-500 blend is and what the research has actually used it for. Each is a direct answer first, context second.
Mechanism and Combination
These answers cover how each peptide works and what the "synergy" of the combination does — and does not — rest on.
Efficacy by Tissue
These answers cover the tissue-specific findings — wound, tendon and ligament, muscle — and the consistent caveat that the evidence is single-compound and largely rodent.
Dose, Route, and Handling
These answers cover the practical dosing and reconstitution questions, with the same honest frame throughout: no validated dose for the blend.
Safety and the Tumor Signal
These answers cover the safety and tumor signal questions honestly: no controlled human safety data for the blend, and a real theoretical concern around Thymosin Beta-4.
Regulatory and Access
These answers summarize the regulatory record; the Wolverine legal status and 503A access page covers it in full and cites FDA.